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Metallic Stent Placement in Hemodialysis
Graft Patients after Insufficient Balloon
Dilation
Objective: We wanted to report our experience of metallic stent placement
after insufficient balloon dilation in graft hemodialysis patients.
Materials and Methods: Twenty-three patients (13 loop grafts in the forearm
and 10 straight grafts in the upper arm) underwent metallic stent placement due
to insufficient flow after urokinase thrombolysis and balloon dilation. The indica-
tions for metallic stent deployment included 1) recoil and/or kinked venous steno-
sis in 21 patients (venous anastomosis: 17 patients, peripheral outflow vein: four
patients); and 2) major vascular rupture in two patients. Metallic stents 8 10mm
in diameter and 40 80 mm in length were used. Of them, eight stents were
deployed across the elbow crease. Access patency was determined by clinical
follow-up and the overall rates were calculated by Kaplan-Meier survival analysis.
Results: No procedure-related complications (stent fracture or central migra-
tion) were encountered except for a delayed Wallstent shortening/migration at the
venous anastomosis, which resulted in early access failure. The overall primary
and secondary patency rates ( standard error) of all the vascular accesses in
our 23 patients at 3, 6, 12 and 24 months were 69% 9 and 88% 6, 41% 10
and 88% 6, 30% 10 and 77% 10, and 12% 8 and 61% 13, respectively.
For the forearm and upper-arm grafts, the primary and secondary patency rates
were 51% 16 and 86% 13 vs 45% 15 and 73% 13 at 6 months, and 25%
15 and 71% 17 vs 23% 17 and 73% 13 at 12 months (p = .346 and .224),
respectively. 
Conclusion: Metallic stent placement is a safe and effective means for treating
peripheral venous lesions in dialysis graft patients after insufficient balloon dila-
tion. No statistically difference in the patency rates between the forearm and
upper-arm patient groups was seen. 
ercutaneous transluminal angioplasty (PTA) has become the first choice
for treating most of the dysfunctional vascular access sites in hemodialy-
sis patients. The technical success rate for PTA in the polytetrafluoethyl-
ene (PTFE) graft patients has been reported to be 75 94% (1 4). The randomized,
prospective studies that have compared stents and angioplasty for treating dialysis
graft vein stenosis have suggested that no benefit is gained by routine stent deploy-
ment (5, 6), but PTA alone was not considered appropriate to treat some types of
vascular lesions that are seen in hemodialysis patients, including recoil or kinked
stenosis (7 9) and venous rupture (10 12). The deployment of a metallic stent across
the elbow crease has been reported on (13, 14) and different conclusions have been
reached concerning the access patency for forearm and upperarm grafts (14, 15).
Herein, we report our experience concerning 23 hemodialysis graft patients with
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Pmetallic stent placement after insufficient balloon dilation,
and all the procedures were done in a single institute over
a 6-year period. We report on the overall access patency
rate of our 23 dialysis-graft patients and also the feasibility
of performing stent placement across the elbow crease, and
we compared the results between the upper arm grafts and
the forearm grafts. 
PATIENTS AND METHODS
From December 1998 to February 2005, a total of 1961
angioplasty procedures for dysfunctional hemodialysis
shunts (approximately one half being PTFE grafts) were
performed in our department. Of them, twenty-three
dialysis graft patients underwent metallic stent placement
to treat their peripheral venous lesions. There were 11
male and 12 female patients with ages that ranged from 51
to 85 years (mean age: 71 years). The age of the prosthetic
graft at the time of stent placement was available for 20
patients (87%), with the average age being 12.2 months
(range: 1 31 months). Thirteen grafts were in a loop
configuration in the forearm region and the other 10 grafts
were straight in shape in the upper arm. Twenty-one
patients (91%) had thrombosed grafts at the time of
intervention. Prior percutaneous angioplasty for these
accesses (1 8 times) had been performed in 19 patients
(83%) before stent placement. 
Percutaneous restoration of the thrombosed graft was
performed by employing our modified technique with
infusing 180,000 units of urokinase (Abbokinase; Abbott
Phamacoceuticals, North Chicago, IL) mixed with 2000
units of heparin in 100 ml normal saline at a rate of 75
100 ml/hr into the graft via the side port of a 7F vascular
sheath. The balloon dilations that were done on the venous
anastomosis and the stenotic segments along the peripheral
outflow veins were performed immediately after the initia-
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Fig. 1. A 74-year male patient with a thrombosed loop graft in the left forearm. 
A. The road-map image shows that both the brachial vein (arrow) and basilic vein (arrowhead) were opacified via the downward collat-
eral veins.
B. After balloon dilation (6 & 8 mm in diameter), a persistent narrowing (arrow) of the outflow brachial vein at the elbow region was noted.
Ultrasound exam revealed that this narrowing was caused by external compression from the accompanying brachial artery (not shown).
C. An 8 60 mm nitinol Luminexx stent (arrow) was deployed at the venous anastomosis across the elbow joint. Note the crisscross
appearance of the brachial vessels. A: brachial artery. V: brachial vein. E: elbow joint. 
AB Ction of urokinase infusion. The arterial inflow was usually
established only after the outflow venous patency was
confirmed by fluoroscopy with injecting a small amount of
contrast medium via the vascular sheath. Urokinase was
then infused from either the angio-catheter (RC1 catheter,
Cook or Bard) that was placed at the arterial limb
proximal to the graft and close to the arterial anastomosis
or from the vascular sheath that was placed in the graft
during the later balloon dilation for declotting of any
residual thrombus in both the venous and arterial systems
in the graft-limb. Angioplasty for the vascular stenosis was
performed using a 6 8 40 mm balloon catheter (Tru-
Trac; Bard, Covington, GA) that was inflated to 8 16
atmospheres. Any stenosis that was resistant to conven-
tional balloon dilation was further dilated with using a high
pressure balloon catheter (BlueMax; Medi-tech,
Watertown, MA) inflated up to 25 28 atmospheres.
Recoil stenosis was dilated with a larger balloon (2 mm
larger in diameter than the initial one). Any residual
arterial plug at the arterial limb of the graft after balloon
catheter declotting was further mechanically declotted by
using a Fogarty balloon catheter (Biosensors, Newport
Beach, CA). Vascular leakage was managed by prolonged
low-pressure balloon inflation (5 10 min). After percuta-
neous restoration, a digital subtraction angiogram was
repeated to assess the result of the procedure. 
The indications for metallic stent placement in this study
included: 1) recoil or kinked residual stenosis of at least
50% (seven patients) or > 30% residual stenosis with early
re-occlusion of the graft within a one month interval (14
patients). Seventeen lesions were at the venous anastomosis
(eight forearm grafts and nine upper-arm grafts), while four
lesions of the forearm grafts were in the downstream
outflow veins. The recoil stenosis in one brachial vein was
shown to be compressed by the accompanying brachial
artery (Fig. 1) on the ultrasound images, and two major
vascular leaks after balloon dilations occurred in two
upperarm grafts with a large pseudoaneurysm (Fig. 2) and a
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Fig. 2. A 51-year-old female patient with a thrombosed straight graft over her right upper arm. 
A. A large pseudoaneurysm at the venous anastomosis after PTA was noted, which failed to response to the prolonged balloon inflation.
B. After a nitinol Memotherm stent (8 40 mm) was placed and one session of balloon inflation (5 min), small residual contrast extrava-
sation (arrows) was still noted. 
C. With a second balloon inflation in the stent for another 5 min, the follow-up venogram showed complete exclusion of the pseudoa-
neurysm.
AB Chematoma formation compromising the outflow vein in one
patient each. Wallstent (8 10 mm 40 80 mm, Boston
Scientific; Galway, Ireland) was used in our first eight
patients, while nitinol stents (8 mm 40 80 mm,
Memotherm/Luminexx, Bard, Angiomed, Karlsruhe,
Germany) were deployed thereafter in the other 15
patients. Of them, eight stents (including four Wallstents
and four nitinol stents) were deployed across the elbow
crease while the other 15 stents were deployed in the upper
arm region. The stents were usually deployed with overlap-
ping of the graft matrix for 1 1.5 cm for the venous
anastomotic lesions. The choice of stent was adapted to the
diameter of the blood vessel (usually 1 2 mm larger than
that of the adjacent vessel) and according to the stent size
that was available at that time in our department.
In our study, 2,000 units of heparin were intravenously
administered before the procedure. Conscious sedation was
achieved by using fentanyl citrate (Sublimaze; Abbott
Laboratories, North Chicago, IL) and midazolan hydrochlo-
ride (Versed Roche Pharmaceuticals, Manati’, PR).
Intravenous antibiotic infusion of cephazolin (1 gram) was
routinely given before the procedure for the thrombosed
graft accesses. No anticoagulant was prescribed for patients
after stent placement. An informed consent was obtained
from each patient. This study was approved by the
Institutional Review Board of our hospital.
The patients were followed up by Doppler color
ultrasound and /or telephone communication so that the
patients who did not experience shunt failure would’t have
to undergo repeated angiography. All complications of the
stent placement (including the eight stents placed across
the elbow crease) were recorded. Technical success was
defined as achieving successful hemodialysis for at least
one time after the interventional procedure. Primary
patency was defined as the period from stent deployment
until any intervention for the vascular access was
performed. Secondary patency was defined as the length
of time from stent placement until the access site was lost,
irrespective of the number of interventions. Patients were
considered to be lost to follow-up when the patients died
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Fig. 3. A 74-year-old male patient with a thrombosed straight graft over his left upper arm.
A. Recoil (arrow) and kinked (arrowhead) stenosis at the venous anastomosis after PTA was noted.
B. A Wallstent (10 80 mm) was deployed across the venous anastomosis with overlapping of the stent with the graft matrix (arrow). 
C. Stent shortening and migration caused early re-occlusion of the access one month after its placement.
D. After simple balloon dilation, the vascular flow was restored, but the access was eventually abandoned another month later.
AB C Dwith a patent access. Kaplan-Meier survival analysis was
used to calculate the access patency rates. Log rank testing
was used to determine the difference of patency between
the upper arm grafts and the forearm grafts. A p value <
.05 was considered as statistical significant. 
RESULTS
Technical success was achieved in all patients with a total
of 23 initially deployed stents. No immediate procedure-
related complications occurred. At the time of data
analysis (April 2005), ten vascular accesses were still
functioning with the average follow-up period being 19.2
months (range: 3 50 months). Eight patients died of
causes unrelated to the procedure with the accesses consid-
ered patent at 3 34 months after the initial stent
placement. The other five accesses were abandoned and
these patients underwent surgical recreation at 2 57
months (mean period: 14.8 months). Within the follow-up
period, 46 episodes of re-stenosis/occlusion occurred in 18
patients during 1 57 months of the follow-up period
(mean period: 15.9 months). Of them, five patients
developed new stenosis at a site away from the stent. A
second stent was placed to maintain the access patency in
one patient for a recurrent problem in the previously
stented segment. The other episodes of re-
stenosis/occlusion were managed by simple balloon
dilations. Early re-occlusion ( 1 month) of the access
after stent placement occurred in five patients. Of them,
three accesses were abandoned within a very short time
(1 2 months), while the other two patients still have
functioning accesses for 11 and seven months, respectively,
until the end of the study.
One patient with venous anastomotic recoil (an upper
arm graft) had dislodgement of the deployed stent, which
caused early lost of his access (Fig. 3). No other stent
migrations or fractures (including the eight patients with
stents across the elbow crease) were encountered during
the follow-up period. 
The overall primary patency rates ( standard error) of
the vascular access in our 23 patients at 3, 6, 12 and 24
months were 69% 9, 41% 10, 30% 10 and 12% 8,
respectively. The secondary patency rates of the vascular
access at the same periods were 88% 6, 88% 6, 77%
10, and 61% 13, respectively (Fig. 4). For the forearm
and upperarm grafts, the primary and secondary patency
rates were 51% 16 and 86% 13 vs 45% 15 and 73%
13 at 6 months, and 25% 15 and 71% 17 vs 23%
17 and 73% 13 at 12 months (p = .346 and .224), respec-
tively. A large pseudoaneurysm occurred in one of our
patients who had a poor response to both prolonged
balloon inflation and bare nitinol stent placement, and the
anemysm was completely occluded after two sessions of
balloon inflations (5 minutes each) within the stent (Fig. 2).
The two patients with vascular rupture maintained good
primary patency of their accesses for 13 months and six
months, respectively, till the end of the study. 
DISCUSSION
A high technical success rate (75% 94%) for pharmaco-
mechanical thrombolysis has been reported for restoring
the patency of an occluded dialysis graft (3). The persistent
narrowing (recoil stenosis) at the venous anastomosis after
balloon angioplasty is estimated to occur in 1.6% 15% of
the upper extremity grafts (9) while the incidence of
venous rupture during balloon dilation was reported to be
up to 20% (16). Both recoil stenosis and venous rupture
may result in PTA failure or the early re-occlusion of the
vascular access. In our series, we also found brachial artery
compression to be one of the causes of a stenotic outflow
vein. This phenomenon does not seem to be previously
mentioned in the literature, and its prevalence is unclear.
Further large series concerning the imaging correlation of
the venographic and ultrasonographic findings is warranted
in the subgroup of patients treated with brachio-brachial
shunt. Metallic stent placement is indicated to restore and
maintain the vascular access patency (7 16), although
metallic stent placement across the venous anastomosis
precludes surgical revision of patch angioplasty, which
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Fig. 4. The diagram showed the overall primary and secondary
patency rates of the 23 graft patients after metallic stent
placement.represent only a minority (12 18%) of the surgical graft
salvage procedures due to it conferring a lower cumulative
graft patency (9, 17). 
The overall 1-year primary patency rate in Vogel’s series
(53 graft patients with peripheral lesions) was 20% (15),
and the secondary patency rate of Patel’s study (26
patients with Wallstent across the venous anastomosis) was
50% at one year (9). In our study, the 1-year primary and
secondary patency rates of our 23 patients were 30% and
77%, respectively. These rates were slightly superior to
that of both the series mentioned above, and they were
comparable to those rates to the Funaki’s series (8) of 20
patients with thigh grafts (a 1-year secondary patency rate
of 81%). 
Kolakowski et al. (14), in a retrospective study, reported
a poorer primary patency for forearm grafts as compared
with upper arm grafts (0% vs 17%, respectively, at 1-
year), and they recommended surgical thrombectomy and
revision as the primary treatment for thrombosed dialysis
forearm grafts. On the contrary, Vogel and Parise (15)
have found the that mean period of patency of forearm
grafts was 17.9 months after peripheral stent placement,
compared with an upperarm graft patency period of 6.7
months (p = .014). In our study, although the number of
patients was small, both the primary and secondary
patency rates of the forearm and upper arm grafts showed
no statistical significance. One reason for the poorer
patency in Kolakowski’s series may be attributed to the
selection of stents. They adopted a shorter stent (2 4 cm
in length) to treat the venous lesions, while stents 4 8 cm
in length were used in our patients, and a mean stent
length of 5 cm was used in Vogel’s series. The other
possible cause was that most of the stenotic lesions occur at
the venous anastomosis, and in Kolakowski’s series, none
of the stents was placed across the elbow joint, which
implied that at least two stenotic lesions existed in most of
their forearm graft patients. 
Because of the concern for stent migration or fracture,
most interventionalists are reluctant to place stents in
proximity to a highly mobile joint, particularly at the
elbow joint (13). In Patel’s and Kolakowski’s series (26 and
61 patients, respectively), no stents were placed across the
elbow joint (9, 14). Vogel and Parise (15), in their recent
report, placed stents in 17 patients at the anastomosis of
the lower arm dialysis grafts across or adjacent to the
elbow joint. They found no difference in patency between
these patients and those who had stents placed at other
peripheral venous sites, with only a single instance of
venous dissection occurring in a patient in Vogel et al.’s
study. In our series, we had placed stents across the elbow
crease in eight forearm graft patients without any compli-
cation. The only complication of stent migration in our
series occurred in an upper arm graft. 
Vascular leak after balloon dilation occurred most
frequently at the venous anastomosis of a graft, with 1.7%
of the severe ruptures necessitating stent placement (10
12). In our daily practice, venous rupture after balloon
dilation occurs not infrequently, but in most instances, this
complication can be well managed by prolonged balloon
inflation. There were only two graft patients in our series
who needed stent placement for salvaging the access. This
is because most of the grafts we managed were occluded at
the time of intervention and we dilated the stenotic
segment at the venous anastomosis or the peripheral
outflow stenosis before introducing the arterial inflow. If
vascular leakage is found immediately after PTA, balloon
inflation for 5 10 minutes will usually seal the leak. Thus,
the ensuing urokinase thrombolysis and declotting can be
performed successfully. Yet for an already flow-established
or stenotic dialysis access, a major vascular rupture will
usually fail to respond to conventional management. In
Weber’s article (11), they demonstrated that one vascular
rupture failed to cease bleeding after a bare metallic stent
placement, and this resulted in loss of the access. Using a
covered stent is an alternative to immediate halt extravasa-
tion (10, 12, 18), but this type of stent is twice as
expensive and it requires the insertion of a larger vascular
sheath. Combined bare stent placement and prolonged
balloon dilation within the stent can be applied to these
patients. Covered stents can be reserved to treat the persis-
tent bleeding that is not controlled by the above
mentioned methods. 
From our present study, we consider that it is safe to
place a metallic stent across the elbow joint in hemodialysis
patients. But because 1) this was a retrospective study and
2) the number of patients was small, further studies with
larger numbers of patients are warranted to confirm the
safety and efficacy in these patients, especially in the sub-
groups of patients with the aforementioned specific indica-
tions. The rimary access patency rate of metallic stent
placement in selected patients is not so promising, but
without performing stent deployment, the vascular access
will be inevitably lost in a very short time. With repeated
percutaneous interventions, the secondary access patency
rate in these patients is still satisfactory. 
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